As of April 16, 2025, Samsung Biologics (207940.KS) has a market cap of $51.32 billion USD. According to our data, Samsung Biologics is ranked No.376 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $51.32 B |
8.64%
|
Dec 30, 2024 | $47.24 B |
24.87%
|
Dec 28, 2023 | $37.83 B |
-7.43%
|
Dec 29, 2022 | $40.87 B |
-8.12%
|
Dec 30, 2021 | $44.48 B |
9.32%
|
Dec 30, 2020 | $40.69 B |
90.76%
|
Dec 30, 2019 | $21.33 B |
12.03%
|
Dec 28, 2018 | $19.04 B |
4.18%
|
Dec 28, 2017 | $18.27 B |
145.70%
|
Dec 29, 2016 | $7.44 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Lonza
LONN.SW
|
$47.74 B |
0.916 B
|
![]() Switzerland
|
![]() WuXi AppTec
2359.HK
|
$2.51 B |
-0.090 B
|
![]() China
|
![]() Catalent
CTLT
|
$11.52 B |
0.000 M
|
![]() USA
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Biogen
BIIB
|
$17.12 B |
0.000 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
![]() USA
|
![]() Bayer
BAYN.DE
|
$23.13 B |
0.001 M
|
![]() Germany
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() Roche
ROG.SW
|
$249.63 B |
38.060 B
|
![]() Switzerland
|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
Market Cap | = | 207940.KS Stock Price | * | 207940.KS Shares Outstanding |
= | $721.09 | * | 71.17 M | |
= | $51.32 B |